These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Detecting bone marrow micrometastasis of gastric cancer by magnetic activated cell sorting combined with fluorescent activated cell sorting]. Wang GY; Wang SJ; Li Y; Fan LQ; Song ZC; Wang LL; Zhao Q; Jiao ZK; Zhang ZD; Zhao XF; Wang D Ai Zheng; 2005 May; 24(5):605-10. PubMed ID: 15890107 [TBL] [Abstract][Full Text] [Related]
26. The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence. Janni W; Rack B; Schindlbeck C; Strobl B; Rjosk D; Braun S; Sommer H; Pantel K; Gerber B; Friese K Cancer; 2005 Mar; 103(5):884-91. PubMed ID: 15666325 [TBL] [Abstract][Full Text] [Related]
27. The Results of Stricter Inclusion Criteria in an Immunomagnetic Detection Study of Micrometastatic Cells in Bone Marrow of Uveal Melanoma Patients - Relevance for Dormancy. Eide N; Faye RS; Høifødt HK; Sandvik L; Qvale GA; Faber R; Jebsen P; Kvalheim G; Fodstad Ø Pathol Oncol Res; 2019 Jan; 25(1):255-262. PubMed ID: 29098521 [TBL] [Abstract][Full Text] [Related]
28. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases. Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396 [TBL] [Abstract][Full Text] [Related]
29. Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients. Wong SC; Chan CM; Ma BB; Hui EP; Ng SS; Lai PB; Cheung MT; Lo ES; Chan AK; Lam MY; Au TC; Chan AT Clin Cancer Res; 2009 Feb; 15(3):1005-12. PubMed ID: 19188172 [TBL] [Abstract][Full Text] [Related]
30. Detecting carcinoma cells in peripheral blood of patients with hepatocellular carcinoma by immunomagnetic beads and rt-PCR. Guo J; Yao F; Lou Y; Xu C; Xiao B; Zhou W; Chen J; Hu Y; Liu Z J Clin Gastroenterol; 2007 Sep; 41(8):783-8. PubMed ID: 17700428 [TBL] [Abstract][Full Text] [Related]
31. Immunomagnetic cell enrichment detects more disseminated cancer cells than immunocytochemistry in vitro. Zigeuner RE; Riesenberg R; Pohla H; Hofstetter A; Oberneder R J Urol; 2000 Nov; 164(5):1834-7. PubMed ID: 11025779 [TBL] [Abstract][Full Text] [Related]
32. Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma. Helfrich I; Edler L; Sucker A; Thomas M; Christian S; Schadendorf D; Augustin HG Clin Cancer Res; 2009 Feb; 15(4):1384-92. PubMed ID: 19228739 [TBL] [Abstract][Full Text] [Related]
33. Prognostic significance and diagnostic value of protein S-100 and tyrosinase in patients with malignant melanoma. Andrés R; Mayordomo JI; Visus C; Isla D; Godino J; Escudero P; Saenz A; Ortega E; Lastra R; Lambea J; Aguirre E; Elosegui L; Marcos I; Ruiz-Echarri M; Millastre E; Sáez-Gutierrez B; Asin L; Vidal MJ; Ferrer A; Giner A; Larrad L; Carapeto FJ; Tres A Am J Clin Oncol; 2008 Aug; 31(4):335-9. PubMed ID: 18845991 [TBL] [Abstract][Full Text] [Related]
34. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse. Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY; Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757 [TBL] [Abstract][Full Text] [Related]
35. Molecular staging in stage II and III melanoma patients and its effect on long-term survival. Voit C; Kron M; Rademaker J; Schwürzer-Voit M; Sterry W; Weber L; Ozdemir C; Proebstle T; Keilholz U J Clin Oncol; 2005 Feb; 23(6):1218-27. PubMed ID: 15718319 [TBL] [Abstract][Full Text] [Related]
36. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level. Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789 [TBL] [Abstract][Full Text] [Related]
37. Micrometastasis of a sentinel lymph node in cutaneous melanoma is a significant prognostic factor for disease-free survival, distant-metastasis-free survival, and overall survival. Moehrle M; Schippert W; Rassner G; Garbe C; Breuninger H Dermatol Surg; 2004 Oct; 30(10):1319-28. PubMed ID: 15458529 [TBL] [Abstract][Full Text] [Related]
38. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma. Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Scheibenbogen C; Thiel E; Foerster MH; Keilholz U Clin Cancer Res; 2007 Feb; 13(4):1171-8. PubMed ID: 17317826 [TBL] [Abstract][Full Text] [Related]
39. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma. Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039 [TBL] [Abstract][Full Text] [Related]
40. Detection of MAGE-A transcripts in bone marrow is an independent prognostic factor in operable non-small-cell lung cancer. Sienel W; Mecklenburg I; Dango S; Ehrhardt P; Kirschbaum A; Passlick B; Pantel K Clin Cancer Res; 2007 Jul; 13(13):3840-7. PubMed ID: 17606715 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]